In the ICH model using the AQP4 inhibitor and Aqp4−/− mice, reduced AQP4 expression resulted in an amplified hematoma area and volume, exacerbated neurological deficits, and impeded hematoma clearance. The gene discussed is AQP4; the disease is hematoma.